Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 19 - Hybrid peptides
Patents for C07K 19 - Hybrid peptides (29,428)
11/2012
11/28/2012CN102796183A Insecticidal protein, and coding gene and purposes thereof
11/28/2012CN102793921A Methods for treating tweak-related conditions
11/28/2012CN102154324B Construction method of mycobacterium tuberculosis fusion protein Mtb 10.4-Hsp16.3, expression method thereof, purification method thereof and application thereof
11/28/2012CN102153644B Antigenic peptide for dimerization of epidermal growth factor receptor
11/28/2012CN101199843B Whooping cough genetic engineering blending second unit vaccine and preparing method thereof
11/27/2012US8318421 Hepatitis-C virus testing
11/27/2012US8318173 for treating a patient with cancer comprising a cancer-specific antigen or a nucleic acid encoding the protein to the patient; genetic engineering; drug delivery; kits
11/27/2012CA2666415C Agent containing fused protein of soluble rankl with epitope tag
11/27/2012CA2432525C Streptococcus pyogenes antigens and corresponding dna fragments
11/27/2012CA2347131C Modified peptides as therapeutic agents
11/22/2012WO2012125445A3 Small molecule-dependent inteins and uses thereof
11/22/2012WO2012118559A3 Tetravalent and mixed head bivalent dengue vaccine
11/22/2012US20120295837 Novel antimicrobial agents
11/22/2012US20120294883 Oligomeric receptor ligand pair member complexes
11/22/2012US20120294881 Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto
11/22/2012US20120294879 Consensus sequence for influenza a virus
11/22/2012US20120294858 Use of long-acting recombinant human soluble tumor necrosis factor alpha receptor in manufacture of a medicament for the treatment and/or prophylaxis of hepatic failure
11/22/2012US20120294857 Monomeric Bi-Specific Fusion Protein
11/22/2012US20120294856 Compounds inhibiting cd95 signaling for the treatment of pancreatic cancer
11/22/2012CA2835882A1 Compositions and methods for the alteration of xlhed phenotypes
11/22/2012CA2832739A1 Novel fusion partners for the purpose of crystallizing g-protein coupled receptors
11/21/2012EP2523970A1 Chimeric human beta defensins
11/21/2012EP2523686A2 Liver targeting domain antibodies
11/21/2012CN102791864A UV associated MTRNA fusion transcripts and methods and uses thereof
11/21/2012CN102791727A Peptides and methods for the detection of Lyme disease antibodies
11/21/2012CN102791293A Liver targeting molecules
11/21/2012CN102786599A Application of rice transcription factor Os05g39950 gene
11/21/2012CN102786584A Insecticidal protein, coding gene of insecticidal protein and purpose of insecticidal protein
11/21/2012CN102210860B Mycobacterium tuberculosis TB10.4-F1 fusion protein vaccine and preparation method thereof
11/21/2012CN102210859B Mycobacterium tuberculosis ESAT-6-F2 fusion protein subunit vaccine and preparation method thereof
11/21/2012CN102030829B Anti-melanoma cytotoxic lymphocyte (CTL) multi-epitope peptide and application thereof
11/21/2012CN101768219B Recombinant fusion protein and preparing method and application thereof
11/21/2012CN101665798B Method for preparing recombinant human serum albumin and interferon alpha fusion protein
11/21/2012CN101497666B Double specificity oligopeptide-cefuroxime sodium strengthened fusion protein Ec-LDP-Hr-AE
11/20/2012US8314224 T1R taste receptors and genes encoding same
11/20/2012US8313928 Expression system
11/20/2012US8313927 Ucp4
11/20/2012US8313925 Zinc finger proteins and method for inactivating a dhfr gene in a chinese hamster ovary cell
11/20/2012CA2762042C Chimeric influenza virus-like particles comprising hemagglutinin
11/20/2012CA2692358C Recombinant human interferon-like proteins
11/20/2012CA2560278C Modified bouganin proteins, cytotoxins and methods and uses thereof
11/20/2012CA2380331C Multiple cytokine-antibody complexes
11/15/2012WO2012155124A2 Metallodrugs having improved pharmacological properties, and methods of manufacture and use thereof
11/15/2012WO2012154933A1 Detecting inclusion body myositis
11/15/2012WO2012153620A1 Drug, functional food, method for stabilizing target protein, fused protein, nucleic acid, and recombinant
11/15/2012WO2012152923A1 Whole cell biocatalyst comprising a prenyltransferase
11/15/2012US20120289679 Novel mite allergen
11/15/2012US20120289459 Antiviral peptides from african swine fever virus which prevent the binding of the virus to dlc8
11/15/2012US20120289454 Metallodrugs having improved pharmacological properties, and methods of manufacture and use thereof
11/15/2012US20120288913 Novel fusion partners for the purpose of crystallizing g-protein coupled receptors
11/15/2012US20120288883 Probe reagent for measurement of proteolytic activity
11/15/2012US20120288511 Glucagon/glp-1 receptor co-agonists
11/15/2012US20120288507 Wise binding agents and epitopes
11/15/2012CA2835630A1 Modified biotin-binding protein, fusion proteins thereof and applications
11/15/2012CA2835453A1 Genetically engineered growth factor variants
11/14/2012EP2522724A1 Polypeptide modification method for purifying polypeptide multimers
11/14/2012CN1717417B Novel immunoadhesins for treating and prventing toxicity and pathogen-mediated diseases
11/14/2012CN1668721B Immunoadhesin comprising a glycoprotein VI domain
11/14/2012CN102781476A Methods for improving oral delivery
11/14/2012CN102775502A Alpha-interferon fusion protein
11/14/2012CN102775501A Interleukin 21 (IL-21) medicine for cancer therapy
11/14/2012CN102775500A Chimeric antigen receptor iRGD-scFv (G250)-CD8-CD28-CD137-CD3zeta and application thereof
11/14/2012CN102775499A Application of rice transcription factor Os01g64730 gene
11/14/2012CN102775498A Application of rice transcription factor Os05g41070 genes
11/14/2012CN102775497A TNF (Tumor Necrosis Factor)-related apoptosis-inducing ligand fusion protein and preparation method thereof
11/14/2012CN102775496A Composite medicine for targeted elimination of HIV/SIV
11/14/2012CN102775495A Polypeptide mixture, T cell vaccine and application thereof
11/14/2012CN102775487A Artificial targeted fusion protein and protein conjugate, and preparation method and application thereof
11/14/2012CN102775486A Novel reagent and kit for renal injury monitoring
11/14/2012CN102775478A Foot and mouth disease virus antigen peptide and vaccine
11/14/2012CN102775469A Antigen epitope of influenza A virus nucleocapsid protein, and its use
11/14/2012CN102190732B PGBD-2 fusion defensin, and preparation method and application thereof
11/14/2012CN101906165B Expression product in series of two fish antibacterial peptide genes and expression method thereof
11/13/2012CA2478414C Selective targeting of tumor vasculature using antibody molecules
11/08/2012WO2012150973A1 Compositions for regulating iron homeostasis and methods of using same
11/08/2012US20120283412 Orphan nuclear receptor
11/08/2012US20120283408 Fusion protein binding specifically to constant region of antibody, method of preparing the fusion protein, and method of isolating antibody using the fusion protein
11/08/2012US20120282292 Methods and compositions related to immunogenic fibrils
11/08/2012US20120282290 Mycobacterial Vaccines
11/08/2012US20120282279 Anti-Diabetic Compounds
11/08/2012US20120282274 Targeting of the c-terminal segment of c.difficile toxin b for improved clinical diagnosis, prevention, and treatment
11/08/2012US20120282272 Novel target in the treatment of cytokine release syndrome
11/08/2012US20120282217 Foot and mouth disease virus (fmdv) consensus proteins, coding sequences therefor and vaccines made therefrom
11/08/2012US20120282211 Antibodies and conjugates for modulators of angiogenesis
11/08/2012US20120282176 Method and Constructs for the pH Dependent Passage of the Blood-brain-barrier
11/08/2012CA2825163A1 Compositions for regulating iron homeostasis and methods of using same
11/07/2012EP2520654A1 Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
11/07/2012CN102770458A Compositions and methods for increasing serum half-life of Fc fusion proteins
11/07/2012CN102770457A Antigen presenting cell targeted vaccines
11/07/2012CN102770454A Activatable constructs
11/07/2012CN102766668A Factor VII glycoforms
11/07/2012CN102766645A Oral recombinant protein TAT-GH for promoting ricefield eel growth, and preparation method and application thereof
11/07/2012CN102766605A Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens
11/07/2012CN102766215A Polypeptide with function of synergic targeting treatment of nasopharyngeal carcinoma, nanoparticle carrying the polypeptide and application thereof
11/07/2012CN102766214A Protein tag-containing SUMO fusion protein and application thereof
11/07/2012CN102766210A Human CTLA-4 antibodies and their uses
11/07/2012CN102766204A Glucagon-like peptide-1 mutant polypeptide, its preparation method and application thereof
11/07/2012CN101948546B Fusion protein SAmB as well as coding gene and applications thereof
11/07/2012CN101891814B Anti-osteopontin OPN monoclonal antibody and application thereof
11/07/2012CN101830983B Preparation and application of specific sequence-based aquaporin 4 high titer antibody
1 ... 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 ... 295